TABLE 4.

Gastric SRS Localization Findings in ZES Patients

CharacteristicGastric SRS localization finding
Positive (n = 19)Negative (n = 143)
Diffuse pattern*Diffuse and focal patternTotal positive
Total no. of patients (n = 162)15 (79)4 (21)19 (100)143 (100)
 MEN-1 present (n = 39)12 (63)4 (21)16 (84)23 (16)
 MEN-1 absent (n = 123)3 (16)0 (0)3 (16)120 (84)
Gastric carcinoid present (n = 16)8 (42)4 (21)12 (63)4 (2)
 MEN-1 present (n = 14)8 (42)4 (21)12 (63)2 (1)
 MEN-1 absent (n = 2)0 (0)0 (0)0 (0)2 (1)
Gastric carcinoid absent (n = 146)7 (37)0 (0)7 (37)139 (97)
 MEN-1 present (n = 25)4 (21)0 (0)4 (21)21 (15)
 MEN-1 absent (n = 121)3 (16)0 (0)4 (21)118 (82)
Gastric nodule present with gastric carcinoid (n = 10)§5 (26)3 (16)8 (42)2 (1)
 MEN-1 present (n = 9)5 (26)3 (16)8 (42)1 (0.5)
 MEN-1 absent (n = 1)0 (0)0 (0)0 (0)1 (0.5)
Gastric nodule absent with gastric carcinoid (n = 6)§3 (15)1 (5)4 (21)2 (1)
 MEN-1 present (n = 5)3 (15)1 (5)4 (21)1 (0.5)
 MEN-1 absent (n = 1)0 (0)0 (0)0 (0)1 (0.5)
  • * Gastric SRS localization was initially reported for 6 of 15 patients with diffuse pattern and detected only on detailed review in 9 patients. Each initially unreported patient had MEN, with 8 patients having gastric carcinoid and 2 patients not having gastric carcinoid.

  • Gastric SRS localization was initially unreported for 1 of 4 patients who had MEN with diffuse and focal pattern and detected only on detailed review. This patient had MEN-1 with advanced gastrinoma and invasive carcinoid tumors necessitating total gastrectomy.

  • P < 0.00001 compared with patients with negative SRS (n = 146).

  • § Gastric nodule present or absent refers to endoscopic findings in stomach at time diagnosis of gastric carcinoid tumor was made histologically.

  • Values in parentheses are percentages of patients with either positive or negative SRS localization with indicated SRS pattern and characteristic.